UPDATED May 09, 2024
Companies which may present a buying opportunity after a dip in share price.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NEWBRY | kr3.06 | -5.6% | -43.3% | kr74.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
AXSM | US$73.68 | -0.7% | -5.5% | US$3.6b | US$123.56 | PS13.9x | E65.1% | n/a | Pharmaceuticals & Biotech | ||
AESI | US$22.99 | 4.8% | 34.1% | US$2.5b | US$26.00 | PE20.4x | E49.3% | 3.7% | Energy | ||
ZVRA | US$5.03 | 5.9% | 18.1% | US$215.9m | US$19.00 | PS7.6x | E65.7% | n/a | Pharmaceuticals & Biotech | ||
RCEL | US$8.71 | -0.1% | -44.6% | US$231.2m | US$25.90 | PS4.5x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
A036200 | ₩10,510.00 | -2.4% | 43.6% | ₩314.1b | ₩13,500.00 | PE17.2x | E38.6% | 0.8% | Semiconductors | ||
CAI | AU$0.13 | 4.0% | -29.7% | AU$99.0m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
HHR | AU$0.007 | 0% | -76.7% | AU$19.7m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
301325 | CN¥61.69 | 0.1% | -31.5% | CN¥7.7b | CN¥83.82 | PE22.3x | E24.9% | n/a | Capital Goods | ||
301358 | CN¥39.90 | 13.9% | -6.6% | CN¥30.6b | n/a | PE20.7x | E30.3% | 1.0% | Capital Goods | ||
ACI | ₹629.25 | -4.3% | 14.7% | ₹76.5b | ₹743.00 | PE19.5x | E29.0% | 0.3% | Materials | ||
SEAPT | kr4.60 | -0.4% | -65.3% | kr1.7b | kr11.57 | PB0.9x | E54.2% | n/a | Energy | ||
DIGN | kr1.62 | 1.6% | -55.7% | kr114.2m | kr8.60 | PS1.3x | E139.0% | n/a | Healthcare | ||
CLBIO | kr10.05 | -4.7% | -38.7% | kr216.0m | kr29.00 | PS7x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
SONM | US$0.56 | 3.5% | -42.2% | US$25.0m | US$2.00 | PB1.1x | E139.9% | n/a | Tech | ||
FXPO | UK£0.48 | -2.8% | -56.3% | UK£283.6m | UK£1.41 | PB0.3x | E116.3% | 0% | Materials | ||
300442 | CN¥28.74 | -8.5% | -5.8% | CN¥50.8b | CN¥36.36 | PE25.9x | E28.7% | 1.8% | Software | ||
A101390 | ₩6,950.00 | -14.6% | -33.8% | ₩62.7b | n/a | PB2.7x | E100.8% | n/a | Tech | ||
KCB | KSh30.05 | 1.9% | 5.4% | KSh96.6b | KSh48.65 | PB0.4x | E26.0% | 0% | Banks | ||
SPAGO | kr0.28 | -20.9% | -64.8% | kr63.6m | n/a | PS10.7x | E52.1% | n/a | Pharmaceuticals & Biotech | ||
OX2 | kr42.26 | 6.0% | -41.1% | kr11.5b | kr70.75 | PE13.1x | E29.9% | n/a | Capital Goods | ||
XBRANE | kr0.19 | -7.3% | -99.8% | kr291.2m | n/a | PS1.2x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
FLNC | US$18.75 | -3.8% | -12.3% | US$3.6b | US$30.30 | PS1.1x | E69.0% | n/a | Capital Goods | ||
CABP | UK£1.38 | 5.5% | n/a | UK£350.2m | UK£1.78 | PE15.3x | E34.6% | n/a | Diversified Financials |